Richard D. Francis, President and CEO at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 447,778 shares at $34.22 ($15.3M) on 2026-02-15, disclosed to the SEC on 2026-02-18.
Open-market sale of $15.3M TEVA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.22 | 161,656 | $5.5M | 36.1% |
| 2 | $34.22 | 286,122 | $9.8M | 63.9% |
| Total | $34.22 avg | 447,778 | $15.3M | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $1.5M | — | Filing → |
| TEVA | SELL | 2026-03-05 | $28.7M | — | Filing → |
| TEVA | SELL | 2025-03-06 | $751K | — | Filing → |